Literature DB >> 22801368

Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK.

Mario R Fernandez1, MaLinda D Henry, Robert E Lewis.   

Abstract

Kinase suppressor of Ras 1 (KSR1) and KSR2 are scaffolds that promote extracellular signal-regulated kinase (ERK) signaling but have dramatically different physiological functions. KSR2(-/-) mice show marked deficits in energy expenditure that cause obesity. In contrast, KSR1 disruption has inconsequential effects on development but dramatically suppresses tumor formation by activated Ras. We examined the role of KSR2 in the generation and maintenance of the transformed phenotype in KSR1(-/-) mouse embryo fibroblasts (MEFs) expressing activated Ras(V12) and in tumor cell lines MIN6 and NG108-15. KSR2 rescued ERK activation and accelerated proliferation in KSR1(-/-) MEFs. KSR2 expression alone induced anchorage-independent growth and synergized with the transforming effects of Ras(V12). Similarly, RNA interference (RNAi) of KSR2 in MIN6 and NG108-15 cells inhibited proliferation and colony formation, with concomitant defects in AMP-activated protein kinase (AMPK) signaling, nutrient metabolism, and metabolic capacity. While constitutive activation of AMPK was sufficient to complement the loss of KSR2 in metabolic signaling and anchorage-independent growth, KSR2 RNAi, MEK inhibition, and expression of a KSR2 mutant unable to interact with ERK demonstrated that mitogen-activated protein (MAP) kinase signaling is dispensable for the transformed phenotype of these cells. These data show that KSR2 is essential to tumor cell energy homeostasis and critical to the integration of mitogenic and metabolic signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801368      PMCID: PMC3430199          DOI: 10.1128/MCB.06754-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.

Authors:  Sang-Min Jeon; Navdeep S Chandel; Nissim Hay
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

2.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

Authors:  Min Wu; Andy Neilson; Amy L Swift; Rebecca Moran; James Tamagnine; Diane Parslow; Suzanne Armistead; Kristie Lemire; Jim Orrell; Jay Teich; Steve Chomicz; David A Ferrick
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-13       Impact factor: 4.249

3.  The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis.

Authors:  Robert L Kortum; Diane L Costanzo; Jamie Haferbier; Steven J Schreiner; Gina L Razidlo; Ming-Hoi Wu; Deanna J Volle; Toshiyuki Mori; Hiroshi Sakaue; Nina V Chaika; Oleg V Chaika; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

Authors:  Keith R Laderoute; Khalid Amin; Joy M Calaoagan; Merrill Knapp; Theresamai Le; Juan Orduna; Marc Foretz; Benoit Viollet
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence.

Authors:  Robert L Kortum; Heidi J Johnson; Diane L Costanzo; Deanna J Volle; Gina L Razidlo; Angela M Fusello; Andrey S Shaw; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.

Authors:  Monica Buzzai; Daniel E Bauer; Russell G Jones; Ralph J Deberardinis; Georgia Hatzivassiliou; Rebecca L Elstrom; Craig B Thompson
Journal:  Oncogene       Date:  2005-06-16       Impact factor: 9.867

7.  Murine Ksr interacts with MEK and inhibits Ras-induced transformation.

Authors:  A Denouel-Galy; E M Douville; P H Warne; C Papin; D Laugier; G Calothy; J Downward; A Eychène
Journal:  Curr Biol       Date:  1998-01-01       Impact factor: 10.834

8.  Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK.

Authors:  W Yu; W J Fantl; G Harrowe; L T Williams
Journal:  Curr Biol       Date:  1998-01-01       Impact factor: 10.834

9.  Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.

Authors:  Gina L Razidlo; Robert L Kortum; Jamie L Haferbier; Robert E Lewis
Journal:  J Biol Chem       Date:  2004-09-13       Impact factor: 5.157

10.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade.

Authors:  Matthew J Sanders; Pascal O Grondin; Bronwyn D Hegarty; Michael A Snowden; David Carling
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

View more
  35 in total

Review 1.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

2.  Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP.

Authors:  Maho Takahashi; Yanping Li; Tara J Dillon; Philip J S Stork
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

3.  Expression analysis of LTR-derived miR-1269a and target gene, KSR2 in Sebastes schlegelii.

Authors:  Jennifer Im; Woo Ryung Kim; Hee-Eun Lee; Ahran Kim; Do-Hyung Kim; Yung Hyun Choi; Hee-Jae Cha; Suhkmann Kim; Heui-Soo Kim
Journal:  Genes Genomics       Date:  2019-11-12       Impact factor: 1.839

Review 4.  KSR as a therapeutic target for Ras-dependent cancers.

Authors:  Beth K Neilsen; Danielle E Frodyma; Robert E Lewis; Kurt W Fisher
Journal:  Expert Opin Ther Targets       Date:  2017-04-07       Impact factor: 6.902

5.  AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.

Authors:  Kurt W Fisher; Binita Das; Hyun Seok Kim; Beth K Clymer; Drew Gehring; Deandra R Smith; Diane L Costanzo-Garvey; Mario R Fernandez; Michael G Brattain; David L Kelly; John MacMillan; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2015-09-08       Impact factor: 4.272

6.  AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.

Authors:  Alain Kfoury; Marzia Armaro; Caterina Collodet; Jessica Sordet-Dessimoz; Maria Pilar Giner; Stefan Christen; Sofia Moco; Marion Leleu; Laurence de Leval; Ute Koch; Andreas Trumpp; Kei Sakamoto; Friedrich Beermann; Freddy Radtke
Journal:  EMBO J       Date:  2018-02-12       Impact factor: 11.598

7.  Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation.

Authors:  J Rauch; D Vandamme; B Mack; B McCann; N Volinsky; A Blanco; O Gires; W Kolch
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

Review 8.  A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.

Authors:  Ayesha S Khan; Daniel E Frigo
Journal:  Nat Rev Urol       Date:  2017-02-01       Impact factor: 14.432

Review 9.  The double-edged sword of AMPK signaling in cancer and its therapeutic implications.

Authors:  Sang-Min Jeon; Nissim Hay
Journal:  Arch Pharm Res       Date:  2015-01-10       Impact factor: 4.946

10.  Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation.

Authors:  Robert L Kortum; Mario R Fernandez; Diane L Costanzo-Garvey; Heidi J Johnson; Kurt W Fisher; Deanna J Volle; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2014-07-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.